Insulin resistance in pulmonary arterial hypertension, is it a novel disease modifier?

Background: Recent studies have introduced glucose intolerance and insulin resistance (IR) as novel risk factors in patients with pulmonary arterial hypertension (PAH). Objectives: We aimed to investigate the prevalence of glucose intolerance and IR in patients with PAH and their correlation with fu...

Full description

Bibliographic Details
Main Authors: Nasim Naderi, Pedram Boobejame, Hooman Bakhshandeh, Ahmad Amin, Sepideh Taghavi, Majid Maleki
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Research in Cardiovascular Medicine
Subjects:
Online Access:http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2014;volume=3;issue=3;spage=8;epage=8;aulast=Naderi;type=0